|
1
|
He F, Zhong X, Lin Z, Lin J, Qiu M, Li X
and Hu Z: Plasma exo-hsa_circRNA_0056616: A potential biomarker for
lymph node metastasis in lung adenocarcinoma. J Cancer.
11:4037–4046. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang J, Zhao X, Wang Y, Ren F, Sun D, Yan
Y, Kong X, Bu J, Liu M and Xu S: circRNA-002178 act as a ceRNA to
promote PDL1/PD1 expression in lung adenocarcinoma. Cell Death Dis.
11:322020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Myers DJ and Wallen JM: Lung
Adenocarcinoma. StatPearls.edn Treasure Island, FL: 2022
|
|
5
|
Lin JJ, Cardarella S, Lydon CA, Dahlberg
SE, Jackman DM, Jänne PA and Johnson BE: Five-year survival in
EGFR-mutant metastatic lung adenocarcinoma treated with EGFR-TKIs.
J Thorac Oncol. 11:556–565. 2016. View Article : Google Scholar
|
|
6
|
Luo C, Lei M and Zhang Y, Zhang Q, Li L,
Lian J, Liu S, Wang L, Pi G and Zhang Y: Systematic construction
and validation of an immune prognostic model for lung
adenocarcinoma. J Cell Mol Med. 24:1233–1244. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Teppan J, Barth DA, Prinz F, Jonas K,
Pichler M and Klec C: Involvement of long non-coding RNAs (lncRNAs)
in tumor angiogenesis. Noncoding RNA. 6:422020.
|
|
8
|
Chan JJ and Tay Y: Noncoding RNA:RNA
regulatory networks in cancer. Int J Mol Sci. 19:13102018.
View Article : Google Scholar
|
|
9
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar
|
|
10
|
Li L, Wang M, Mei Z, Cao W, Yang Y, Wang Y
and Wen A: lncRNAs HIF1A-AS2 facilitates the up-regulation of
HIF-1α by sponging to miR-153-3p, whereby promoting angiogenesis in
HUVECs in hypoxia. Biomed Pharmacother. 96:165–172. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ye S, Lu Y, Ru Y, Wu X, Zhao M, Chen J, Xu
M, Huang Q, Wang Y, Shi S, et al: LncRNAs GACAT3 and LINC00152
regulate each other through miR-103 and are associated with
clinicopathological characteristics in colorectal cancer. J Clin
Lab Anal. 34:e233782020. View Article : Google Scholar
|
|
12
|
Feng Y, Ge Y, Wu M, Xie Y, Wang M, Chen Y
and Shi X: Long NonCoding RNAs regulate inflammation in diabetic
peripheral neuropathy by acting as ceRNAs targeting miR-146a-5p.
Diabetes Metab Syndr Obes. 13:413–422. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang T, Liu H, Mao R, Yang H, Zhang Y,
Zhang Y, Guo P, Zhan D, Xiang B and Liu Y: The lncRNA RP11-142A22.4
promotes adipogenesis by sponging miR-587 to modulate Wnt5β
expression. Cell Death Dis. 11:4752020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang L, He S, Wang Y, Zhu X, Shao W, Xu Q
and Cui Z: miRNA-20a suppressed lipopolysaccharide-induced HK-2
cells injury via NFκB and ERK1/2 signaling by targeting CXCL12. Mol
Immunol. 118:117–123. 2020. View Article : Google Scholar
|
|
15
|
Ji W, Diao YL, Qiu YR, Ge J, Cao XC and Yu
Y: LINC00665 promotes breast cancer progression through regulation
of the miR-379-5p/LIN28B axis. Cell Death Dis. 11:162020.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xue M, Tao W, Yu S, Yan Z, Peng Q, Jiang F
and Gao X: lncRNA ZFPM2-AS1 promotes proliferation via
miR-18b-5p/VMA21 axis in lung adenocarcinoma. J Cell Biochem.
121:313–321. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xue J and Zhang F: LncRNA LINC00511 plays
an oncogenic role in lung adenocarcinoma by regulating PKM2
expression via sponging miR-625-5p. Thorac Cancer. 11:2570–2579.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang X, Du L, Han J, Li X, Wang H, Zheng
G, Wang Y, Yang Y, Hu Y and Wang C: Novel long non-coding RNA
LINC02323 promotes epithelial-mesenchymal transition and metastasis
via sponging miR-1343-3p in lung adenocarcinoma. Thorac Cancer.
11:2506–2516. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tan Y, Zhang T, Zhou L, Liu S and Liang C:
MiR-34b-3p represses the multidrug-chemoresistance of bladder
cancer cells by regulating the CCND2 and P2RY1 genes. Med Sci
Monit. 25:1323–1335. 2019. View Article : Google Scholar
|
|
20
|
Zhuang XF, Zhao LX, Guo SP, Wei S, Zhai JF
and Zhou QH: miR-34b inhibits the migration/invasion and promotes
apoptosis of non-small-cell lung cancer cells by YAF2. Eur Rev Med
Pharmacol Sci. 23:2038–2046. 2019.
|
|
21
|
Cao DN, Shi JJ, Wu N and Li J: Modulation
of miR-139-5p on chronic morphine-induced, naloxone-precipitated
cAMP overshoot in vitro. Metab Brain Dis. 33:1501–1508. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao W, Geng D, Li S, Chen Z and Sun M:
LncRNA HOTAIR influences cell growth, migration, invasion, and
apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer
Med. 7:842–855. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shetty A, Venkatesh T, Kabbekodu SP,
Tsutsumi R and Suresh PS: LncRNA-miRNA-mRNA regulatory axes in
endometrial cancer: A comprehensive overview. Arch Gynecol Obstet.
Feb 18–2022.(Epub ahead of print). doi: 10.1007/s00404-022-06423-5,
2022. View Article : Google Scholar
|
|
25
|
Dastsooz H, Alizadeh A, Habibzadeh P,
Nariman A, Hosseini A, Mansoori Y and Haghi-Aminjan H:
LncRNA-miRNA-mRNA networks of gastrointestinal cancers representing
common and specific LncRNAs and mRNAs. Front Genet. 12:7919192022.
View Article : Google Scholar
|
|
26
|
Zhang Y, Hu G, Zhang Z, Jing Y, Tao F and
Ye M: CircRNA_0043691 sponges miR-873-3p to promote metastasis of
gastric cancer. Mamm Genome. 32:476–487. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Arun K, Arunkumar G, Bennet D,
Chandramohan SM, Murugan AK and Munirajan AK: Comprehensive
analysis of aberrantly expressed lncRNAs and construction of ceRNA
network in gastric cancer. Oncotarget. 9:18386–18399. 2018.
View Article : Google Scholar
|
|
28
|
Xu S, Yang F, Liu R, Li X, Fan H, Liu J,
Wei S, Chen G, Chen J and Da Y: Serum microRNA-139-5p is
downregulated in lung cancer patients with lytic bone metastasis.
Oncol Rep. 39:2376–2384. 2018.PubMed/NCBI
|
|
29
|
Liu WW, Wang H, Chen XH, Fu SW and Liu ML:
miR-34b-3p may promote antiplatelet efficiency of aspirin by
inhibiting thromboxane synthase expression. Thromb Haemost.
119:1451–1460. 2019. View Article : Google Scholar
|
|
30
|
Song F, Cai A, Ye Q, Chen X, Lin L and Hao
X: MiR-34b-3p impaired HUVECs viability and migration via targeting
PDK1 in an in vitro model of gestational diabetes mellitus. Biochem
Genet. 59:1381–1395. 2021. View Article : Google Scholar
|
|
31
|
Shen B, Wang L, Xu Y, Wang H and He S:
LncRNA GAS5 silencing attenuates oxygen-glucose
deprivation/reperfusion-induced injury in brain microvascular
endothelial cells via miR-34b-3p-dependent regulation of EPHA4.
Neuropsychiatr Dis Treat. 17:1667–1678. 2021. View Article : Google Scholar
|
|
32
|
Feng H, Ge F, Du L, Zhang Z and Liu D:
MiR-34b-3p represses cell proliferation, cell cycle progression and
cell apoptosis in non-small-cell lung cancer (NSCLC) by targeting
CDK4. J Cell Mol Med. 23:5282–5291. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lu X, Xu C, Xu Z, Lu C, Yang R, Zhang F
and Zhang G: Piperlongumine inhibits the growth of non-small cell
lung cancer cells via the miR-34b-3p/TGFBR1 pathway. BMC Complement
Med Ther. 21:152021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li Q, Liang X, Wang Y, Meng X, Xu Y, Cai
S, Wang Z, Liu J and Cai G: miR-139-5p inhibits the
epithelial-mesenchymal transition and enhances the chemotherapeutic
sensitivity of colorectal cancer cells by downregulating BCL2. Sci
Rep. 6:271572016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang N, Guo W, Ren K, Li W, Jiang Y, Sun
J, Dai W and Zhao W: LncRNA AFAP1-AS1 supresses miR-139-5p and
promotes cell proliferation and chemotherapy resistance of
non-small cell lung cancer by competitively upregulating RRM2.
Front Oncol. 9:11032019. View Article : Google Scholar
|
|
36
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tao X, Wu X, Huang T and Mu D:
Identification and analysis of dysfunctional genes and pathways in
CD8(+) T cells of non-small cell lung cancer based on RNA
sequencing. Front Genet. 11:3522020. View Article : Google Scholar
|
|
38
|
Wang C, Tan S, Liu WR, Lei Q, Qiao W, Wu
Y, Liu X, Cheng W, Wei YQ, Peng Y and Li W: RNA-Seq profiling of
circular RNA in human lung adenocarcinoma and squamous cell
carcinoma. Mol Cancer. 18:1342019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Seo D, Roh J, Chae Y and Kim W: Gene
expression profiling after LINC00472 overexpression in an NSCLC
cell line1. Cancer Biomark. 32:175–188. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen L, Huang T, Zhang YH, Jiang Y, Zheng
M and Cai YD: Identification of novel candidate drivers connecting
different dysfunctional levels for lung adenocarcinoma using
protein-protein interactions and a shortest path approach. Sci Rep.
6:298492016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu C, Zhang YH, Huang T and Cai Y:
Identification of transcription factors that may reprogram lung
adenocarcinoma. Artif Intell Med. 83:52–57. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang L, Cui Y, Zhang L, Sheng J, Yang Y,
Kuang G, Fan Y, Zhang Q and Jin J: The silencing of CCND2 by
promoter aberrant methylation in renal cell cancer and analysis of
the correlation between CCND2 methylation status and clinical
features. PLoS One. 11:e01618592016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Dong Q, Meng P, Wang T, Qin W, Qin W, Wang
F, Yuan J, Chen Z, Yang A and Wang H: MicroRNA let-7a inhibits
proliferation of human prostate cancer cells in vitro and in vivo
by targeting E2F2 and CCND2. PLoS One. 5:e101472010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chang L, Guo R, Yuan Z, Shi H and Zhang D:
LncRNA HOTAIR regulates CCND1 and CCND2 expression by sponging
miR-206 in ovarian cancer. Cell Physiol Biochem. 49:1289–1303.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Di W, Li Q, Shen W, Guo H and Zhao S: The
long non-coding RNA HOTAIR promotes thyroid cancer cell growth,
invasion and migration through the miR-1-CCND2 axis. Am J Cancer
Res. 7:1298–1309. 2017.PubMed/NCBI
|
|
46
|
Han W, Wang L, Zhang L, Wang Y and Li Y:
Circular RNA circ-RAD23B promotes cell growth and invasion by
miR-593-3p/CCND2 and miR-653-5p/TIAM1 pathways in non-small cell
lung cancer. Biochem Biophys Res Commun. 510:462–466. 2019.
View Article : Google Scholar : PubMed/NCBI
|
